Previous close | 0.0060 |
Open | 0.0060 |
Bid | 0.0050 x N/A |
Ask | 0.0000 x N/A |
Day's range | 0.0060 - 0.0060 |
52-week range | 0.0030 - 0.0090 |
Volume | |
Avg. volume | 5,918,666 |
Market cap | N/A |
Beta (5Y monthly) | 0.76 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Data from a preclinical study shows that treatment with Alterity's (ATHE) lead candidate improved motor performance and general function in monkeys with experimentally-induced Parkinson's disease.
Key Insights Alterity Therapeutics' Annual General Meeting to take place on 28th of November CEO David Stamler's total...